Ocugen stock soars after partner Bharat Biotech COVID-19 vaccine candidate shows 81% efficacyMarket Watch • 03/03/21
Ocugen Shares Are Trading Higher On Its Partner's COVID-19 Vaccine Candidate Showing 81% EfficacyBenzinga • 03/03/21
European Commission Grants Ocugen Orphan Medicinal Product Designation for Gene Therapy Product Candidate, OCU400, For the Treatment of Both Retinitis Pigmentosa and Leber Congenital AmaurosisGlobeNewsWire • 02/23/21